1. Drug-Coated Balloons: A Safe and Effective Alternative to Drug-Eluting Stents in Small Vessel Coronary Artery Disease
- Author
-
Thuzar Tint Nyein, Fahim Haider Jafary, Dasdo Antonius Sinaga, Jason Kwok Kong Loh, Alyssa Sim, Hee Hwa Ho, Timothy James Watson, Paul Jau Lueng Ong, Yau Wei Ooi, and Julian K.B. Tan
- Subjects
medicine.medical_specialty ,Acute coronary syndrome ,business.industry ,medicine.medical_treatment ,Lumen (anatomy) ,Retrospective cohort study ,030204 cardiovascular system & hematology ,Balloon ,medicine.disease ,Surgery ,Coronary artery disease ,03 medical and health sciences ,0302 clinical medicine ,Angioplasty ,Diabetes mellitus ,Cohort ,Medicine ,Radiology, Nuclear Medicine and imaging ,030212 general & internal medicine ,Cardiology and Cardiovascular Medicine ,business - Abstract
Background Drug-coated balloons (DCB) have been used to treat de novo small vessel coronary disease (SVD), with promising results and shorter dual antiplatelet therapy (DAPT) duration compared to drug-eluting stents (DES). We compared safety and effectiveness of the two treatments at 1 year. Methods We reviewed 3,613 angioplasty cases retrospectively from 2011 to 2013 and identified 335 patients with SVD treated with device diameter of ≤2.5 mm. DCB-only angioplasty was performed in 172 patients, whereas 163 patients were treated with second-generation DES. Results DCB patients had smaller reference vessel diameter (2.22 ± 0.30 vs. 2.44 ± 0.19 mm, P
- Published
- 2016